These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36041942)

  • 61. Behavioral flexibility predicts increased ability to resist excessive methamphetamine self-administration.
    Istin M; Thiriet N; Solinas M
    Addict Biol; 2017 Jul; 22(4):958-966. PubMed ID: 26969296
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Methamphetamine Induces Systemic Inflammation and Anxiety: The Role of the Gut-Immune-Brain Axis.
    Davidson M; Mayer M; Habib A; Rashidi N; Filippone RT; Fraser S; Prakash MD; Sinnayah P; Tangalakis K; Mathai ML; Nurgali K; Apostolopoulos V
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232524
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hippocampal neurogenesis interferes with extinction and reinstatement of methamphetamine-associated reward memory in mice.
    Che X; Bai Y; Cai J; Liu Y; Li Y; Yin M; Xu T; Wu C; Yang J
    Neuropharmacology; 2021 Sep; 196():108717. PubMed ID: 34273388
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Altered methamphetamine place conditioning in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccine.
    Haile CN; Kosten TA; Shen XY; O'Malley PW; Winoske KJ; Kinsey BM; Wu Y; Huang Z; Lykissa ED; Naidu N; Cox JA; Arora R; Kosten TR; Orson FM
    Am J Addict; 2015 Dec; 24(8):748-55. PubMed ID: 26584468
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A stress steroid triggers anxiety via increased expression of α4βδ GABAA receptors in methamphetamine dependence.
    Shen H; Mohammad A; Ramroop J; Smith SS
    Neuroscience; 2013 Dec; 254():452-75. PubMed ID: 23994152
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.
    Newton TF; Reid MS; De La Garza R; Mahoney JJ; Abad A; Condos R; Palamar J; Halkitis PN; Mojisak J; Anderson A; Li SH; Elkashef A
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1037-45. PubMed ID: 18664303
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers.
    De La Garza R; Newton TF; Haile CN; Yoon JH; Nerumalla CS; Mahoney JJ; Aziziyeh A
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):141-6. PubMed ID: 22230648
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens.
    Sim MS; Soga T; Pandy V; Wu YS; Parhar IS; Mohamed Z
    Metab Brain Dis; 2017 Dec; 32(6):1767-1783. PubMed ID: 28681200
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats.
    Karimi-Haghighi S; Haghparast A
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():307-313. PubMed ID: 28870635
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Influencing Antibody-Mediated Attenuation of Methamphetamine CNS Distribution through Vaccine Linker Design.
    Gooyit M; Miranda PO; Wenthur CJ; Ducime A; Janda KD
    ACS Chem Neurosci; 2017 Mar; 8(3):468-472. PubMed ID: 27958709
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effects of minocycline in improving of methamphetamine withdrawal syndrome in male mice.
    Ghavimi H; Bayani Ershadi AS; Dastvar S; Hosseini MJ
    Drug Chem Toxicol; 2022 Sep; 45(5):2319-2327. PubMed ID: 34182834
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hapten optimization for cocaine vaccine with improved cocaine recognition.
    Ramakrishnan M; Kinsey BM; Singh RA; Kosten TR; Orson FM
    Chem Biol Drug Des; 2014 Sep; 84(3):354-63. PubMed ID: 24803171
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relapse of methamphetamine-seeking behavior in C57BL/6J mice demonstrated by a reinstatement procedure involving intravenous self-administration.
    Yan Y; Nitta A; Mizoguchi H; Yamada K; Nabeshima T
    Behav Brain Res; 2006 Mar; 168(1):137-43. PubMed ID: 16413064
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Development and Characterization of an scFv-Fc Fusion-Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse.
    Hay CE; Ewing LE; Hambuchen MD; Zintner SM; Small JC; Bolden CT; Fantegrossi WE; Margaritis P; Owens SM; Peterson EC
    J Pharmacol Exp Ther; 2020 Jul; 374(1):16-23. PubMed ID: 32245884
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Genetic vulnerability of methamphetamine dependence].
    Moriya Y; Kasahara Y; Sora I
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Aug; 33(4):155-60. PubMed ID: 25069251
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: A pilot randomized clinical trial.
    Moore DJ; Pasipanodya EC; Umlauf A; Rooney AS; Gouaux B; Depp CA; Atkinson JH; Montoya JL
    Drug Alcohol Depend; 2018 Aug; 189():154-160. PubMed ID: 29958127
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preclinical efficacy of an anti-methamphetamine vaccine using E6020 adjuvant.
    Arora R; Haile CN; Kosten TA; Wu Y; Ramakrishnan M; Hawkins LD; Orson FM; Kosten TR
    Am J Addict; 2019 Feb; 28(2):119-126. PubMed ID: 30701618
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins.
    Baruffaldi F; Kelcher AH; Laudenbach M; Gradinati V; Limkar A; Roslawski M; Birnbaum A; Lees A; Hassler C; Runyon S; Pravetoni M
    Mol Pharm; 2018 Nov; 15(11):4947-4962. PubMed ID: 30240216
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Methods in drug abuse models: comparison of different models of methamphetamine paradigms.
    Kobeissy FH; Mitzelfelt JD; Fishman I; Morgan D; Gaskins R; Zhang Z; Gold MS; Wang KK
    Methods Mol Biol; 2012; 829():269-78. PubMed ID: 22231820
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Atomoxetine Efficacy in Methamphetamine Dependence during Methadone Maintenance Therapy.
    Rabiey A; Hassani-Abharian P; Farhad M; Moravveji AR; Akasheh G; Banafshe HR
    Arch Iran Med; 2019 Dec; 22(12):692-698. PubMed ID: 31823620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.